6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione

C60H70Cl2F3N15O7S2 — CID 160631270

IUPAC6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione
SMILESCC1(C)CC(c2cccc3[nH]ncc23)CCN1S(C)(=O)=O.O=C1NC(=O)C2(CCN(c3cc(C(F)(F)F)cc4[nH]ncc34)CC2)N1.O=C1NCCC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O=S(=O)(C1CC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C15H17ClN4O.C15H18ClN3O2S.C15H14F3N5O2.C15H21N3O2S/c16-10-7-12-11(9-18-19-12)13(8-10)20-5-2-15(3-6-20)1-4-17-14(15)21;16-11-7-13(14-9-17-18-15(14)8-11)10-3-5-19(6-4-10)22(20,21)12-1-2-12;16-15(17,18)8-5-10-9(7-19-22-10)11(6-8)23-3-1-14(2-4-23)12(24)20-13(25)21-14;1-15(2)9-11(7-8-18(15)21(3,19)20)12-5-4-6-14-13(12)10-16-17-14/h7-9H,1-6H2,(H,17,21)(H,18,19);7-10,12H,1-6H2,(H,17,18);5-7H,1-4H2,(H,19,22)(H2,20,21,24,25);4-6,10-11H,7-9H2,1-3H3,(H,16,17)
InChIKeyRHYLHLRKYGUKNH-UHFFFAOYSA-N
MW1305.35 g/mol
LogP9.45
Rot. Bonds7

About 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione

6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione (PubChem CID 160631270) has the molecular formula C60H70Cl2F3N15O7S2 and a molecular weight of 1305.35 g/mol. Its IUPAC name is 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione.

Molecular Properties

Compound Name6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione
PubChem CID160631270
Molecular FormulaC60H70Cl2F3N15O7S2
Molecular Weight1305.35 g/mol
Exact Mass1303.44
IUPAC Name6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione
SMILESCC1(C)CC(c2cccc3[nH]ncc23)CCN1S(C)(=O)=O.O=C1NC(=O)C2(CCN(c3cc(C(F)(F)F)cc4[nH]ncc34)CC2)N1.O=C1NCCC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O=S(=O)(C1CC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C15H17ClN4O.C15H18ClN3O2S.C15H14F3N5O2.C15H21N3O2S/c16-10-7-12-11(9-18-19-12)13(8-10)20-5-2-15(3-6-20)1-4-17-14(15)21;16-11-7-13(14-9-17-18-15(14)8-11)10-3-5-19(6-4-10)22(20,21)12-1-2-12;16-15(17,18)8-5-10-9(7-19-22-10)11(6-8)23-3-1-14(2-4-23)12(24)20-13(25)21-14;1-15(2)9-11(7-8-18(15)21(3,19)20)12-5-4-6-14-13(12)10-16-17-14/h7-9H,1-6H2,(H,17,21)(H,18,19);7-10,12H,1-6H2,(H,17,18);5-7H,1-4H2,(H,19,22)(H2,20,21,24,25);4-6,10-11H,7-9H2,1-3H3,(H,16,17)
InChIKeyRHYLHLRKYGUKNH-UHFFFAOYSA-N
XLogP9.45
TPSA283.26 Ų
H-Bond Donors7
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms89
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001305.35
LogP ≤ 59.45
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione?
The IUPAC name of 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione (CID 160631270) is 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione.
What is the SMILES notation for 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione?
The canonical SMILES for 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione is CC1(C)CC(c2cccc3[nH]ncc23)CCN1S(C)(=O)=O.O=C1NC(=O)C2(CCN(c3cc(C(F)(F)F)cc4[nH]ncc34)CC2)N1.O=C1NCCC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O=S(=O)(C1CC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.
What is the InChIKey of 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione?
The InChIKey is RHYLHLRKYGUKNH-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17ClN4O.C15H18ClN3O2S.C15H14F3N5O2.C15H21N3O2S/c16-10-7-12-11(9-18-19-12)13(8-10)20-5-2-15(3-6-20)1-4-17-14(15)21;16-11-7-13(14-9-17-18-15(14)8-11)10-3-5-19(6-4-10)22(20,21)12-1-2-12;16-15(17,18)8-5-10-9(7-19-22-10)11(6-8)23-3-1-14(2-4-23)12(24)20-13(25)21-14;1-15(2)9-11(7-8-18(15)21(3,19)20)12-5-4-6-14-13(12)10-16-17-14/h7-9H,1-6H2,(H,17,21)(H,18,19);7-10,12H,1-6H2,(H,17,18);5-7H,1-4H2,(H,19,22)(H2,20,21,24,25);4-6,10-11H,7-9H2,1-3H3,(H,16,17).
What are the key properties of 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione?
6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione has a molecular weight of 1305.35 g/mol, XLogP of 9.45, 7 rotatable bonds, 7 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 6-chloro-4-(1-cyclopropylsulfonylpiperidin-4-yl)-1H-indazole;8-(6-chloro-1H-indazol-4-yl)-2,8-diazaspiro[4.5]decan-1-one;4-(2,2-dimethyl-1-methylsulfonylpiperidin-4-yl)-1H-indazole;8-[6-(trifluoromethyl)-1H-indazol-4-yl]-1,3,8-triazaspiro[4.5]decane-2,4-dione is sourced from PubChem (CID 160631270), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).